Cognitive Decline Startup Advisory Board Member

Cognitive Decline Strategy, Governance & Value Creation - Advisory Board MemberWe are seeking a highly accomplished executive or recognized thought leader in cognitive decline, brain health, or neurodegenerative disease to join our Advisory Board and provide strategic, governance-level guidance to a high-growth startup addressing the expanding cognitive health crisis. This role is structured to support disciplined scaling, capital efficiency, and long-term enterprise value creation in a rapidly evolving and highly scrutinized sector.The ideal candidate brings deep expertise in mild cognitive impairment (MCI), Alzheimer’s disease, vascular cognitive impairment, and related neurodegenerative conditions, along with experience aligning clinical innovation with scalable business models, reimbursement pathways, regulatory frameworks, and investor expectations. We are specifically seeking a leader who understands how to translate scientific rigor into durable competitive advantage and defensible market positioning.As an Advisory Board Member, you will partner closely with the CEO and executive team to provide independent strategic counsel on long-term clinical positioning, competitive differentiation, value-based care strategy, outcomes validation, regulatory considerations, and scalable go-to-market execution. Your guidance will help ensure the company builds a disciplined, evidence-based platform capable of delivering measurable clinical and economic outcomes while maintaining operational excellence and ethical integrity in serving cognitively vulnerable populations.From a governance perspective, you will provide objective oversight on strategic priorities, product roadmap alignment, risk mitigation, data integrity, and responsible innovation. You will help leadership balance growth ambition with clinical credibility and regulatory prudence, ensuring that expansion is sustainable and aligned with long-term stakeholder value.This is an opportunity to shape a category-defining organization positioned at the intersection of aging demographics, rising healthcare costs, and advances in neuroscience and digital health. Your expertise will directly influence how the company builds defensible infrastructure, strengthens investor confidence, forges strategic partnerships, and generates durable impact and enterprise value in the cognitive health market.About Alzheimer’s Treatment Centers of America (ATCA)Alzheimer’s Treatment Centers of America (ATCA) leverages Artificial Intelligence (AI) and Personalized Precision Medicine to transform the treatment of Alzheimer’s disease, dementia, and cognitive impairment, including brain fog associated with Long COVID. This is about delivering structured, data driven treatment to patients today. ATCA goes beyond traditional diagnosis to identify underlying contributors to neurodegeneration and cognitive dysfunction, implementing individualized treatment protocols designed to slow progression and improve functional outcomes.Our multidisciplinary leadership team includes experienced healthcare executives, neuroscientists, AI engineers, and clinical specialists working together to deploy a scalable, neurologist supported clinic model nationwide. As we expand, we are building a governance framework supported by senior physician leaders who understand clinical rigor, operational scalability, and health system integration.Why Now?Growing Community Need: Our Palm Beach Gardens/Jupiter clinic is fully operational and actively treating patients in a high visibility medical corridor adjacent to Cleveland Clinic. Originally launched in a former urgent care space to enable rapid deployment, the clinic reached capacity quickly, with appointments booked months in advance reflecting significant unmet demand for proactive cognitive care.Three additional clinics are in development, with broader national expansion underway. ATCA is building a repeatable, specialist supported specialty model that expands access to structured cognitive evaluation and longitudinal management while maintaining clinical rigor and operational scalability.Seamless System Integration: ATCA’s care model integrates within the existing healthcare ecosystem. Treatments are reimbursed by Medicare, Medicare Advantage, and most major commercial insurers, reducing barriers to access and accelerating patient adoption.Focused on Outcomes: In a study utilizing ATCA’s AI driven protocol, 75% of patients with mild cognitive impairment demonstrated no further cognitive decline. This represents a data driven, proactive approach that complements traditional management pathways and emphasizes measurable outcomes.Advanced Therapeutic Options: Eligible patients may have access to TB006, an FDA approved therapy available for compassionate use, providing a potential treatment pathway for certain dementias, including Alzheimer’s disease.Physician Supported: ATCA’s protocols are backed by an experienced Medical Advisory Board of top doctors and scientists. As we expand nationally, we are strengthening this advisory infrastructure with senior surgical leaders who bring expertise in clinical governance, quality assurance, scalability, and system-based care delivery. See our Medical Advisory Board:https://atca.ai/medical-advisory-board/Key AchievementsProprietary AI Precision Engine: ATCA has built and deployed a defensible AI driven precision medicine platform that optimizes Alzheimer’s treatment at the individual patient level, creating strong clinical differentiation and long-term data network effects. High Margin, Replicable Clinic Model: Engineered a scalable specialty clinic platform targeting 44% EBITDA margins, driven by optimized staffing ratios, high-acuity service mix, and strong reimbursement dynamics designed for rapid multi-market expansion. Massive, Underserved Market Opportunity: Positioned to capture share in a $355B U.S. Alzheimer’s market and a $1.5T global opportunity, addressing one of the largest and fastest-growing unmet needs in healthcare.Embedded Revenue Generating Research Infrastructure: Integrated micro research capabilities within each clinic to generate real world evidence, pharmaceutical partnerships, clinical trial participation, and recurring high margin ancillary revenue streams.Responsibilities IncludeCognitive Health & Clinical Strategy: Provide advisory oversight on evidence based cognitive decline models spanning early risk identification, screening, diagnosis, longitudinal management, and advanced care planning. Guide development of clinically rigorous frameworks that improve cognitive and functional outcomes, enhance quality of life, reduce caregiver burden, and support measurable impact across diverse populations experiencing mild cognitive impairment and related disorders.Scalable Brain Health Platform Development: Advise on building and scaling interdisciplinary, technology enabled, and community integrated cognitive care solutions. Support the development of standardized yet adaptable care pathways that integrate neurology, geriatrics, primary care, behavioral health, and caregiver services while maintaining scientific integrity, operational discipline, and scalability.Value-Based & Reimbursement Strategy: Guide strategic positioning within Medicare Advantage, ACO, and other value based reimbursement environments. Advise on outcomes validation, risk stratification methodologies, utilization management, quality reporting, documentation integrity, and payer alignment to ensure sustainable growth and defensible economic value.Governance & Enterprise Risk Oversight: Provide independent board level perspective on strategic priorities, product roadmap alignment, regulatory exposure, data governance, clinical risk management, and ethical innovation in cognitively vulnerable populations. Help ensure responsible scaling, compliance alignment, and long term stakeholder value creation.Executive & Growth Advisory: Partner with founders and executive leadership to align clinical and scientific strategy with product development, market differentiation, strategic partnerships, capital strategy, and investor communications. Support positioning that strengthens credibility with payers, providers, life sciences partners, and growth stage investors.Innovation & Ecosystem Insight: Provide guidance on digital diagnostics, AI-enabled cognitive assessment tools, remote monitoring, biomarker integration, and emerging therapeutic advancements. Advise on navigating evolving regulatory, reimbursement, and competitive dynamics within the broader cognitive health and neurodegenerative disease ecosystem.Why Join Us?Strategic Influence: Shape the governance architecture of rapidly expanding AI enabled brain health platforms.Board Level Engagement: Contribute at the advisory level without day to day operational responsibility.Impact at Scale: Help ensure innovative cognitive care models expand responsibly while preserving the highest standards of neurosurgical oversight.Enterprise Level Perspective: Apply surgical leadership experience to one of the most urgent and fastest growing areas in healthcare.Clinical Integrity During Innovation: Safeguard rigor, accountability, and patient safety as precision medicine platforms scale nationally.Compensation / PerksEquity Participation Opportunities: Select advisory roles may include equity options aligned with long term strategic contribution.Strategic Investment Access: Advisory members may be offered optional participation in growth financing initiatives where applicable.Equal Opportunity CommitmentWe are committed to fostering inclusive advisory leadership. Diverse perspectives strengthen governance, innovation, and patient outcomes. Senior surgeons from all backgrounds are encouraged to participate in shaping the future of structured, scalable brain health care.